Abstract
reduce the effect of cancer immunotherapy. Although studies have demonstrated that the number and suppressive activity of Treg increase with age, it is not clear whether these changes correlate with a higher incidence of tumours in the elderly. This study was designed to explore the relationship between increase in CD4 + CD25 +
FOXP3
+ Treg and the higher risk of lung cancer in the elderly.
Methods
Seventy lung cancer patients and 60 sex-and age-matched controls were recruited. Both groups were divided into three subgroups based on their age (young, middle-aged, or elderly). The proportion of CD4 + CD25 + FOXP3 + /CD4 + T cells was detected using flow cytometry, and the level of FOXP3 mRNA in the peripheral blood was examined with realtime RT-PCR.
Results
The levels of CD4 + CD25 + FOXP3 + /CD4 + T cells and FOXP3 mRNA were significantly higher in lung cancer patients than in healthy controls (t = 7.16, P < 0.01 and t = 3.65, P < 0.01, respectively). Within the healthy groups, the elderly group had larger proportion of CD4 
Introduction
The International Agency for Research on Cancer has indicated that the incidence of malignancy increases with age [1] . The tumour morbidity and mortality of individuals in their 80's were reported to be three times higher than those of individuals 55 years of age [2, 3] . As for tumour type, lung cancer is the most common worldwide, and in more than 70% patients, the disease has unfortunately progressed into the intermediate or late stages upon their diagnosis. Concerning China, it is estimated that there will be more than 1 million new cases of lung cancer by 2025 [4, 5] . Therefore, the relationship between age and lung cancer has emerged as a hot topic in recent years. On the other hand, recent evidence [6, 7] The diagnosis of COPD was established in accordance to the GOLD report [13] . No statistical differences existed in the sex ratio, mean age, average body weight or smoking history between the patients and controls (all P > 0.05). Both groups were divided into three subgroups according to their age: young (18-44 years), middle-aged (45-59 years), and elderly (60-90 years). The authors could not identify individual participants during the research. The study was reviewed and approved by Ethical Committee of Rushan People's Hospital, Binzhou Medical University. All participants were informed about the purpose of the study and signed the consent form prior to the experiment.
Materials and methods

Patients and controls
Blood collection and cell storage
A total of 5 ml anti-coagulated blood was collected from each subject by nurse and processed within 2 h. Peripheral blood mononuclear cells (PBMCs) were isolated using Ficoll lymphocyte separation medium (Chemical Reagent Co., Ltd, China). An aliquot of 100 μL (1 Ã 10 6 cells) suspension was separately added to the marked No. 1 (CD4 single labelled), No. 2 (CD4, CD25, FOXP3 labelled), and No. 3 (blank control) flow tubes. To the remainder of the sample, 1 mL RNAiso Plus (Shanghai Hengxin Chemical Reagent Co., Ltd, China) was added, and the samples were preserved at -80˚C for the measurement of FOXP3 mRNA levels, which would be conducted within two weeks.
Flow cytometry analysis
A regulatory T cell staining kit (eBioscience, San Diego, USA) was used according to the manufacturer's directions. Surface molecules were stained using a standard procedure, with a fluorescein isothiocyanate (FITC)-CD4-antibody and an allophycocyanin conjugated (APC)-CD25 antibody, and incubated at 4˚C for 15 min. After being washed with flow cytometry staining buffer, permeabilization working solution was added, and the cells were stained with a phycoerythrin-conjugated (PE) FOXP3 antibody and incubated at 4˚C for 30 min. Finally, the cells were washed, resuspended with flow cytometry staining buffer, and analysed with Gallios flow cytometry (Beckman Coulter, USA). The proportion of positive cells was determined using WinMDI version 2.8 software (The Scripps Institute, USA).
Real-time RT-PCR
DNA-free RNA templates were extracted from the PBMCs preserved at -80˚C using an RNA isolation kit (ShineGene Bio-Technologies Inc., Shanghai, China). Reverse transcription was performed according to the manufacturer's instructions (Takara Biotechnology Co., LTD, China) after assessing RNA concentration and quality by A260/A280. Real-time PCR assays were carried out on an ABI 7500 Real-time PCR System with the SYBR 1 Premix Ex TaqTM kit (Takara Biotechnology Co., Ltd.). A 20 μl reaction system contained 10 μl SYBR Premix Ex Taq, 0.4 μl ROX Reference Dye II, 0.4 μl each primer (FOXP3, 5'-CAGCACATTCCCAGAGTT CCT-3' and 5'-AGCGTGGCGTAGGTGAAAG-3'), 2 μl cDNA, and 6.8 μl dH 2 O. The PCR protocol began at 94˚C for 30 s, followed by 40 cycles at 94˚C for 20 s and 55˚C for 34 s. β-ACTIN (5'-ACCGAGCGCGGCTACAG-3' and 5'-CTTAATGTCACGCACGATTTCC-3') was used as a housekeeping gene to normalize the level of each of the gene transcripts.
Statistical analysis
Data was collected immediately after the experiments. Values were presented as the mean ± SD. Statistical analysis was performed using SAS version 8.0 software. Student's t test was used to examine the differences between the patient and healthy groups. One-way analysis of variance was performed to compare means across multiple groups. P values < 0.05 were considered statistically significant.
Results
The percentages of CD4 mRNA was considerably higher in patients than in controls by student's t test (t = 3.65, P < 0.01, shown in Table 3 , Fig 2) . Among the healthy groups, FOXP3 mRNA levels in the peripheral blood also increased with age according to one-way analysis of variance (middleaged vs. young, F = 5.51, P < 0.01; elderly vs. middle-aged, F = 30.49, P < 0.01). The elderly lung cancer group displayed the highest expression level of FOXP3 mRNA (3.14 ± 1.30), suggesting that FOXP3 mRNA increases with both age and lung cancer. immune evasion [6] . The forkhead transcription factor FOXP3 has also been verified as a key player in Treg function [14, 15] . Our experiment confirmed that, within the same age group, the proportion of CD4 mRNA in the peripheral blood were significantly higher in lung cancer patients than in healthy controls. Miyara et.al [16] found that human FOXP3 the TNM staging and lymph node metastasis status, which is consistent with previous studies [17, 18] . However, no significant difference is found between COPD and non-COPD group, which is in accordance with DB Tan The expression level of FOXP3 mRNA in the peripheral blood was considerably higher in patients than in controls by student's t test (P < 0.01). FOXP3 mRNA levels also increased with age according to one-way analysis of variance: a P < 0.01 compared with the young healthy group, b P < 0.01 compared with the middle-aged healthy group, c P < 0.01 compared with the young lung cancer group, d P < 0.01 compared with the middle-aged lung cancer group. 
